energy
发表于 2025-3-21 18:34:14
书目名称Drugs for HER-2-positive Breast Cancer影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0283218<br><br> <br><br>书目名称Drugs for HER-2-positive Breast Cancer影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0283218<br><br> <br><br>书目名称Drugs for HER-2-positive Breast Cancer网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0283218<br><br> <br><br>书目名称Drugs for HER-2-positive Breast Cancer网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0283218<br><br> <br><br>书目名称Drugs for HER-2-positive Breast Cancer被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0283218<br><br> <br><br>书目名称Drugs for HER-2-positive Breast Cancer被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0283218<br><br> <br><br>书目名称Drugs for HER-2-positive Breast Cancer年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0283218<br><br> <br><br>书目名称Drugs for HER-2-positive Breast Cancer年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0283218<br><br> <br><br>书目名称Drugs for HER-2-positive Breast Cancer读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0283218<br><br> <br><br>书目名称Drugs for HER-2-positive Breast Cancer读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0283218<br><br> <br><br>
Agnosia
发表于 2025-3-21 21:20:57
2296-6056 le source of information for researchers and clinicians from.Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in m
lacrimal-gland
发表于 2025-3-22 02:27:31
https://doi.org/10.1007/978-3-0346-0094-1HER-2-positive Breast Cancer; Pertuzumab; Second Generation targeted Therapies; Trastuzumab; antibodies
手段
发表于 2025-3-22 07:00:30
978-3-0348-0318-2Springer Basel AG 2011
间谍活动
发表于 2025-3-22 08:50:27
Drugs for HER-2-positive Breast Cancer978-3-0346-0094-1Series ISSN 2296-6056 Series E-ISSN 2296-6064
垫子
发表于 2025-3-22 14:52:05
http://reply.papertrans.cn/29/2833/283218/283218_6.png
垫子
发表于 2025-3-22 19:24:32
Milestones in Drug Therapyhttp://image.papertrans.cn/e/image/283218.jpg
掺假
发表于 2025-3-22 23:25:52
Book 2011ch as lapatinib (Tykerb/Tyverb). Moreover, a multiplicity of novel, improved irreversibly acting small molecular HER tyrosine kinase inhibitors are in the pipeline of many drug developing companies and are being evaluated in the clinical setting..
Pseudoephedrine
发表于 2025-3-23 05:06:07
http://reply.papertrans.cn/29/2833/283218/283218_9.png
dainty
发表于 2025-3-23 06:05:08
Trastuzumab as Adjuvant Treatment for Early Stage HER-2-positive Breast Cancer,